TNFRSF1B and ovarian carcinoma: It has been found that strong expression of the tumour necrosis factor receptor 2 (TNFR2) on regulatory T cells (Tregs) in ovarian cancer tissue creates a potent immunosuppressive tumour microenvironment and is associated with poor clinical response [8,9].